Modeling Heterogeneity of Triple‐Negative Breast Cancer Uncovers a Novel Combinatorial Treatment Overcoming Primary Drug Resistance

Triple‐negative breast cancer (TNBC) is a highly aggressive breast cancer subtype characterized by a remarkable molecular heterogeneity. Currently, there are no effective druggable targets and advanced preclinical models of the human disease. Here, a unique mouse model (MMTV‐R26(Met) mice) of mammar...

Descripción completa

Detalles Bibliográficos
Autores principales: Lamballe, Fabienne, Ahmad, Fahmida, Vinik, Yaron, Castellanet, Olivier, Daian, Fabrice, Müller, Anna‐Katharina, Köhler, Ulrike A., Bailly, Anne‐Laure, Josselin, Emmanuelle, Castellano, Rémy, Cayrou, Christelle, Charafe‐Jauffret, Emmanuelle, Mills, Gordon B., Géli, Vincent, Borg, Jean‐Paul, Lev, Sima, Maina, Flavio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Full Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7856896/
https://www.ncbi.nlm.nih.gov/pubmed/33552868
http://dx.doi.org/10.1002/advs.202003049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7856896/
https://www.ncbi.nlm.nih.gov/pubmed/33552868
http://dx.doi.org/10.1002/advs.202003049

Ejemplares similares